Breast Cancer
Showing NaN - NaN of 191
Toxicities of Salvage Treatment in Locoregionally Recurrent
Not yet recruiting
- Breast Cancer
- Salvage treatment (surgery and/or radiation therapy)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 5, 2023
Nipple-areolar Complex Sensation According to Incision Types in
Completed
- Breast Cancer
- Nipple Sparing Mastectomy
- Nipple sparing mastecomy with different incision placements
-
Seoul, Korea, Republic ofGangnamSeverance Hospital
Jun 15, 2023
Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul
Recruiting
- Breast Cancer
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
Recruiting
- Breast Cancer
- Whole breast irradiation +/- tumor bed boost
-
Seoul, Korea, Republic ofSamsung Medical Center
May 30, 2023
Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- Breast MRI for Breast Cancer Detection
-
Busan, BusanJin-Gu, Korea, Republic of
- +3 more
Apr 2, 2023
A Post Marketing Surveillance on Piqray in Korea
Recruiting
- Breast Cancer
- Piqray
-
Deogyang Gu Goyang Si, Gyeonggi Do, Korea, Republic of
- +4 more
Jan 16, 2023
Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,
Recruiting
- Breast Neoplasms
- +2 more
- Trastuzumab Deruxtecan
- +5 more
-
Springdale, Arkansas
- +203 more
Jan 13, 2023
An Observational Study of Kadcyla Safety in Breast Cancer
Completed
- Breast Cancer
-
Busan, Korea, Republic of
- +37 more
Jan 10, 2023
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
Recruiting
- Ovarian Cancer
- +3 more
-
Busan, Korea, Republic of
- +17 more
Jan 9, 2023
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with
Not yet recruiting
- Breast Cancer
- +4 more
- Ovarian function suppression with endocrine treatments
-
Seoul, Korea, Korea, Republic ofGangnam Severance Hospital
Dec 18, 2022
Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)
Recruiting
- Breast Cancer
- Head and Neck Cancer
- Palbociclib
- +3 more
-
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
- +3 more
Dec 14, 2022